The case 'JANSSEN PHARMACEUTICALS, INC et al v. et al' (docket 19-cv-21590) remains pending in the District of New Jersey E1. The litigation involves multiple plaintiffs, including 2:22-cv-03553 MARTINEZ and 2:22-cv-03547 MCKINNEY-BROWN, against Janssen Pharmaceuticals and Pharmascience Inc. Juryvine classifies this matter as civil litigation in federal courts E6.
What the court said
On May 8, 2026, the court issued 22 separate orders dismissing cases involving Janssen Pharmaceuticals as a defendant. These included dismissals for 2:22-cv-03545 ZRINSKI, 2:22-cv-03191 WOULARD, and 2:22-cv-03260 MORRISON [E7, [E10, E28]]. Each dismissal order cited the same procedural basis, though specific reasons were not detailed in the public records [E8, [E11, E29]]. The court's actions followed a pattern of dismissing cases with similar legal frameworks, including 2:22-cv-03184 TRACY and 2:22-cv-03189 WEIKER [E22, E36].
Why it matters
The dismissals occurred across multiple related cases, including 2:22-cv-02513 MENDEZ and 2:22-cv-03148 MOORE, which share legal vocabulary overlaps with the main case [E53, E55]. Juryvine's similarity index shows connections to cases like 'FERRELL v. JANSSEN PHARMACEUTICALS, INC' (22-cv-03473) with a 0.69 similarity score E60. These dismissals suggest coordinated litigation efforts, with 17 cases dismissed under the same procedural framework on May 8, 2026 [E7-E51]. The pattern raises questions about the strategic management of these cases by Janssen's legal team.
What comes next
While the court dismissed these cases, the litigation scene remains complex. Janssen Pharmaceuticals appears as a plaintiff in 2:19-cv-21590, while multiple other cases name it as a defendant E52. The dismissals may prompt plaintiffs to refile or seek appeals, though no such actions are documented in the ledger. The court's repeated use of dismissal orders on May 8, 2026, indicates procedural efficiency but leaves unresolved questions about the merits of the underlying claims E79. Legal observers will monitor whether these dismissals set precedents for similar cases in the district.
What The Record Shows
Docket Record
- The case "JANSSEN PHARMACEUTICALS, INC et al v. PHARMASCIENCE INC. et al" (docket 19-cv-21590) is pending before District of New Jersey E1.
- JANSSEN PHARMACEUTICALS, INC et al v E3.
- PHARMASCIENCE INC. et al is an active civil matter in District of New Jersey under docket 19-cv-21590 E4.
- The dispute currently identifies 2:22-cv-03553 MARTINEZ, 2:22-cv-03547 MCKINNEY-BROWN, and 2:22-cv-03260 MORRISON on one side and JANSSEN PHARMACEUTICALS, INC and PHARMASCIENCE INC on the other E5.
- Juryvine classifies the matter around civil litigation, federal courts E6.
Parties And Court
- 2:19-cv-21590 JANSSEN PHARMACEUTICALS, INC appears in this matter as Plaintiff E52.
- 2:22-cv-02513 MENDEZ appears in this matter as Plaintiff E53.
- 2:22-cv-03130 GERMOSEN DE MONTAS appears in this matter as Plaintiff E54.
- 2:22-cv-03148 MOORE appears in this matter as Plaintiff E55.
- 2:22-cv-03184 TRACY appears in this matter as Plaintiff E56.
- 2:22-cv-03189 WEIKER appears in this matter as Plaintiff E57.